| Company Name: |
Cayman Chemical Company
|
| Tel: |
800-364-9897 |
| Email: |
sales@caymanchem.com |
| Products Intro: |
Product Name:AB-CHMINACA metabolite M7
CAS:2748157-34-6
|
| Company Name: |
Cayman Chemical Company
|
| Tel: |
(800) 364-9897 |
| Email: |
cayman@caymanchem.com |
| Products Intro: |
Product Name:AB-CHMINACA metabolite M7
CAS:2748157-34-6
|
|
| | Aspartic acid, N-[[1-(cyclohexylmethyl)-1H-indazol-3-yl]carbonyl]-3-methyl- Basic information |
| | Aspartic acid, N-[[1-(cyclohexylmethyl)-1H-indazol-3-yl]carbonyl]-3-methyl- Chemical Properties |
| Boiling point | 643.3±50.0 °C(Predicted) | | density | 1.41±0.1 g/cm3(Predicted) | | solubility | DMF: 5 mg/ml; DMSO: 10 mg/ml; DMSO:PBS(pH7.2) (1:1): 0.5 mg/ml; Ethanol: 3 mg/ml | | pka | 3.18±0.25(Predicted) |
| | Aspartic acid, N-[[1-(cyclohexylmethyl)-1H-indazol-3-yl]carbonyl]-3-methyl- Usage And Synthesis |
| Description | AB-CHMINACA is a synthetic cannabinoid (CB) that is an analog of AB-FUBINACA , a potent agonist of the central CB1 receptor (Ki = 0.9 nM).1,2 AB-CHMINACA metabolite M7 is a potential metabolite produced during metabolism of AB-CHMINACA in vivo. The physiological and toxicological properties of this compound are not known. This product is intended for forensic and research applications. | | References | 1. Uchiyama, N., Matsuda, S., Wakana, D., et al. New cannabimimetic indazole derivatives, N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide (AB-PINACA) and N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide (AB-FUBINACA) identified as designer drugs in illegal products Forensic Toxicol. 31(1),93-100(2013).
2. Buchler, I.P., Hayes, M.J., Hedge, S.G., et al. Indazole derivatives ,1-283(2009). |
| | Aspartic acid, N-[[1-(cyclohexylmethyl)-1H-indazol-3-yl]carbonyl]-3-methyl- Preparation Products And Raw materials |
|